News

March 01, 2010
Half Yearly Report and Accounts - Period Ended 31 December 2009
January 31, 2010
Appendix 4C - Quarter Ended December 31st 2009
December 24, 2009
Appendix 3B Quotation of Exercised Options
December 15, 2009
Appointment of L-Dex® Distributor For China and Region
December 14, 2009
Release of Restricted Securities on 31 December 2009
November 24, 2009
University Study Supports ImpediMed Devices
November 23, 2009
Annual General Meeting Voting Results
November 23, 2009
Annual General Meeting CEO Presentation
November 12, 2009
Impedimed Announces Category 1 Current Procedural Terminology (CP ...
November 11, 2009
ImpediMed Appoints A Chief Financial Officer
November 06, 2009
ImpediMed Appoints Vice President Of Global Finance
November 06, 2009
Change Of Director`s Interest Notice - M. Panaccio
November 06, 2009
Change In Substantial Holding - Starfish Deemed Interest
October 28, 2009
ImpediMed Ceases To Be A Substantial Shareholder In Itself Re Esc ...
October 27, 2009
Quarterly Cashflow Report
October 26, 2009
Notice of Annual General Meeting
October 26, 2009
Appendix 3B Release of Escrow Shares
October 23, 2009
New Publication Asks - “Is ImpediMed BIS Technology The New Gol ...
October 22, 2009
ImpediMed Announces Scientific Meeting Review By Leading US Healt ...
October 21, 2009
VP of Quality and Regulatory Appointed
October 09, 2009
Escrow Share Release
September 11, 2009
Appointment of Company Secretary
August 21, 2009
Details of Share Register Address Change
August 18, 2009
CFO Role Relocation To The USA
August 07, 2009
Appendix 3B - Staff and Consultant Performance Shares
July 31, 2009
Company Update - Financial Year 2009
July 31, 2009
Appendix 4C - Quarterly Report- Quarter Ended June 30, 2009
July 28, 2009
North Carolina Legislation Breaks New Ground Specifying Mandated ...
July 14, 2009
University Of Sydney Publication Suggesting L-Dex Most Suited To ...
July 14, 2009
Pending Escrow Release - Aorora Technologies Pty Ltd
July 10, 2009
University College London Hospital and Blackburn With Darwen PCT ...
July 08, 2009
Ceasing To Become A Substantial Holder - Versant
July 07, 2009
Change In Substantial Holding -Starfish Technology Fund 1
July 07, 2009
Change In Substantial Holding - Orbis Investment Management
July 07, 2009
Change In Substantial Holding - IPD Deemed In Itself
July 07, 2009
Becoming A Substantial Holder - Wilson HTM Investment Group
July 06, 2009
Change of Directors Interest Notice - Michael Panaccio
July 06, 2009
Change of Directors Interest Notice - Mel Bridges
July 06, 2009
Change of Directors Interest Notice - Martin Kriewaldt
July 06, 2009
Change of Directors Interest Notice - James Hazel
July 06, 2009
Change of Directors Interest Notice - Greg Brown
July 06, 2009
Change of Directors Interest Notice - Dr Cherrell Hirst
June 29, 2009
Independent Article in The Weekend Australian Newspaper
June 17, 2009
ImpediMed's SFB7 Selected for Use in the (US) Western States 36th ...
June 16, 2009
NHS Great Western Hospital Swindon, Adopts L-DEX U400 For Pre-emp ...
June 10, 2009
Shareholder Letter and Offer Summary Dispatch
June 09, 2009
Change In Substantial Holding - Thorpe Road Nominees Pty Ltd
June 05, 2009
Change In Substantial Holding
June 05, 2009
Ceasing To Become A Substantial Shareholder-Greg Brown
June 05, 2009
Ceasing To Become A Substantial Shareholder- Mel Bridges
June 04, 2009
Change In Substantial Holding-Starfish
June 04, 2009
ImpediMed ASX Codes and Rights Trading
June 04, 2009
Change In Substantial Holding For Macquarie Group Limited
June 03, 2009
Notice Under Section 708A (5) (e) of the Corporations Act
June 03, 2009
ImpediMed Confirms Settlement of Placement
May 28, 2009
Appendix 3B New Issue Announcement, Application for Quotation of ...
May 28, 2009
Renounceable Entitlement Offer
May 28, 2009
Letter To Option Holders
May 28, 2009
ImpediMed Announces Capital Raising
May 28, 2009
Company Presentation
May 28, 2009
Cleansing Notice
May 26, 2009
Trading Halt
May 07, 2009
Response to ASX Query Regarding Appendix 4C
April 30, 2009
Quarterly Update
April 30, 2009
Appendix 4C Quarter Ended 31st March 2009
April 07, 2009
Change In Substantial Holding- ImpediMed Deemed In Itself.
April 06, 2009
Change of Director's Interest Notice-Deemed-Dr Panaccio.
April 06, 2009
Change In Substantial Holding-Starfish Deemed Interests
March 30, 2009
Presentation for Australian and US Investment Roadshow
March 23, 2009
Change of Director's Interest Notice
March 19, 2009
Study In Major Cancer Journal Confirms That Lymphoedema Signific ...
March 12, 2009
Escrow Release
March 12, 2009
Change of Director's Interest Notice
March 12, 2009
Appendix 3B for ESOP Options and Shares
March 09, 2009
New Publications Add To The Burden Of Evidence Supporting Pre-ope ...
March 05, 2009
Change of Director's Interest Notice
March 05, 2009
Change of Director's Interest Notice
March 05, 2009
Change of Director's Interest Notice
March 05, 2009
Change of Director's Interest Notice
February 25, 2009
Half Yearly Report and Accounts - Period Ended 31 Dec 2008
February 25, 2009
Half Year Results Business Update - Period Ended 31 Dec 2008
February 25, 2009
Appendix 4D - Period Ended 31st Dec 2008
February 02, 2009
Change in Substantial Holding
January 30, 2009
Company Update and Share Placement
January 30, 2009
Cleansing Notice - Sec 708A(5)(e)
January 30, 2009
Appendix 4C - Quarter Ended December 31st 2008
January 30, 2009
Appendix 3B - $2M Placement
January 19, 2009
ImpediMed Wins Innovation Shootout in USA
January 15, 2009
Australian Consulate General Announcement - ImpediMed Wins 2009 A ...
January 12, 2009
US Breast Surgeons Board Member and ImpediMed in Arizona Star
January 06, 2009
Sydney BCRG Study Corroborates Use of ImpediMed Devices